Deal date
KANDO id: 768121
Financial Transaction:
Series D
Corinth MedTech Inc
Currency
United States Dollar
Value in original currency
12,000,000
Value in USD
12,000,000
Note
The proceeds from the financing will be used "to launch the commercialization of the Veloxion System, which received U.S. Food and Drug Administration (FDA) 510(k) clearance in May 2019."
Lead investor
| Investor | Country | Notes | |
|---|---|---|---|
|
Aethan Capital Inc |
Initial investment. | |
|
Shangbay Capital LLCVenture capital firm focused on early stage investments in the US medical device technologies, biotechnology, and mobile healthcare sectors. |
United States | Initial investment. |